Julie Gerberding

Julie Gerberding    (civil servant)
Born	22 August 1955
Nationality	US
Alma mater	Case Western Reserve University
Member of	Covid Commission Planning Group, The Commons Project
Approved Merck vaccine Gardasil as CDC Director, salary $172,000. Then made around $25 million from stock sales when working for Merck.  Director of the Centers for Disease Control and Prevention In office 3 July 2002 - 20 January 2009 Preceded by Julie Gerberding  Acting Director of the Centers for Disease Control and Prevention In office 31 March 2002 - 3 July 2002 Succeeded by Julie Gerberding

Dr Julie Gerberding served as the director of the U.S. Centers for Disease Control and Prevention (CDC) for then to be rewarded with a position as executive vice president for strategic communications, global public policy & population health and the chief patient officer at Merck.

Gerberding became a nationally-recognized figure during the 2001 anthrax attacks in the United States. As the Acting Deputy Director of National Center for Infectious Diseases, Gerberding was a prominent spokeswoman for the CDC during daily briefings regarding the attacks and aftermath.

AIDS research

During her medical residency at San Francisco General Hospital, Gerberding treated some of the first hospitalized AIDS patients. She completed several studies on the risks of HIV to healthcare workers, created guidelines to prevent their infections, and established a treatment and research unit focused on HIV/AIDS cases among the urban poor.

Revolving Door

Merck’s Gardasil vaccine was approved and mandated by the CDC when Gerberding was the director of the CDC. She went from about $172,000 in salary to around $25 million in compensation from stock sales at Merck and CERN.

In late 2009, Gerberding became president of Big Pharma corporation Merck's vaccines division. According to form 4 SEC filings, between 2015 and 2020, Gerberding sold $23,968,010 in Merck stock. Since July of 2016, she has served on the board of directors at the Cerner Corporation, a health care technology corporation.[ On July 17, 2020 she sold 36,285 units of CERN stock worth $2,902,800.

 

Events Participated in

Event	Start	End	Location(s)	Description
Clade X	15 May 2018	15 May 2018		A pandemic/biowarfare preparation exercise by Johns Hopkins Center for Health Security. Held May 2018.
WEF/Annual Meeting/2008	23 January 2008	27 January 2008	World Economic Forum Switzerland	At the 2008 summit, Klaus Schwab called for a coordinated approach, where different 'stakeholders' collaborate across geographical, industrial, political and cultural boundaries."
WEF/Annual Meeting/2011	26 January 2011	30 January 2011	World Economic Forum Switzerland	2229 guests in Davos, with the theme: "Shared Norms for the New Reality".
WEF/Annual Meeting/2012	25 January 2012	29 January 2012	Switzerland	2113 guests in Davos
WEF/Annual Meeting/2013	23 January 2013	27 January 2013	World Economic Forum Switzerland	2500 mostly unelected leaders met to discuss "leading through adversity"
WEF/Annual Meeting/2017	17 January 2017	20 January 2017	World Economic Forum Switzerland	2950 known participants, including prominently Bill Gates. "Offers a platform for the most effective and engaged leaders to achieve common goals for greater societal leadership."
WEF/Annual Meeting/2019	22 January 2019	25 January 2019	World Economic Forum Switzerland	"The reality is that we are in a Cold War [against China] that threatens to turn into a hot one."
WEF/Annual Meeting/2020	21 January 2020	24 January 2020	World Economic Forum Switzerland	This mega-summit of the world's ruling class and their political and media appendages happens every year, but 2020 was special, as the continuous corporate media coverage of COVID-19 started more or less from one day to the next on 20/21 January 2020, coinciding with the start of the meeting.

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.